Search Results
Algernon NeuroScience testing psychedelic DMT to treat Stroke
Algernon NeuroScience begins human trials using DMT to treat stroke
Algernon launching research program for treatment of stroke using Psychedelic drug DMT
Algernon Pharmaceuticals Forms Algernon NeuroScience Subsidiary to Advance DMT Stroke Program
Algernon Pharmaceuticals subsidiary Algernon NeuroScience doses first patient in stroke study
DMT Improves Stroke Recovery! #shorts #NewTreatments
Algernon Pharmaceuticals Stroke/DMT Clinical Program
Market One - Algernon Pharmaceuticals - First Company to Investigate DMT as a Treatment for Stroke
Algernon Pharmaceuticals plans Phase 2 stroke and TBI study after successful DMT single dose study
Algernon NeuroScience reports successful second cohort dosing in DMT clinical study
Algernon Pharmaceuticals gains approval for Phase 1 clinical study of DMT for treatment of stroke
Algernon gets approval for groundbreaking phase 1 study of DMT for stroke
